BRAF and colorectal carcinoma: A case report on the patient with MSI-high CRC who responded to pembrolizumab was presented in part: Sehdev A, Cramer HM, Ibrahim AA, et al. Pathological complete response with anti-pd1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.